Cardiovascular Events
Showing 26 - 50 of >10,000
N-terminal Pro-B-type Natriuretic Peptide in Type 2 Diabetes
Recruiting
- Type2diabetes
- +2 more
-
Singapore, SingaporeSingapore General Hospital
Feb 22, 2023
Pollutants in Atherosclerotic Plaque and Cardiovascular Events
Recruiting
- Atherosclerosis
- analysis of carotid atherosclerotic plaque
-
Naples, ItalyCelestino Sardu
Jun 12, 2023
Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to
Recruiting
- Abdominal Aortic Aneurysm
- Cardiovascular Events
- Carotid Artery Reactivity test (CAR test)
- Arterial Stiffness
-
Nijmegen, Gelderland, Netherlands
- +6 more
Nov 10, 2022
Obstructive Sleep Apnea, Pulmonary Edema Cardiac Cause Trial in Recife, Sao Paulo (CPAP, Nasal Strips)
Suspended
- Obstructive Sleep Apnea
- Pulmonary Edema Cardiac Cause
- CPAP
- Nasal Strips
-
Recife, Sao Paulo, Brazil
- +3 more
Dec 27, 2022
Cardiovascular Disease Trial in Sao Paulo (polipillV1, polipillV2, usual care)
Withdrawn
- Cardiovascular Disease
- polipillV1
- +2 more
-
Sao Paulo, BrazilInstituto de Ensino e Pesquisa - IEP - HCor
Sep 20, 2022
Aging, Autonomic Nervous System Activity and Cardiovascular
Active, not recruiting
- Healthy
-
Saint-Etienne, FranceCentre Hospitalier de Saint-Etienne
Apr 5, 2022
Obesity, Morbid, Cardiovascular Diseases Trial in Hamilton (Bariatric surgery)
Recruiting
- Obesity, Morbid
- Cardiovascular Diseases
- Bariatric surgery
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare Hamilton
Mar 14, 2022
Association Between Lipid Profiles and Cardiovascular Events
Active, not recruiting
- Dyslipidemias
- Cardiovascular Diseases
- Measurement of lipid profiles
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 2, 2022
Coronary Artery Disease Trial in United States (Colchicine, Placebo)
Not yet recruiting
- Coronary Artery Disease
- Colchicine
- Placebo
-
Long Beach, California
- +4 more
Nov 15, 2022
Coronary Artery Disease Progression Trial (Intensive lipid-lowering control, Moderate-intensity lipid-lowering control)
Not yet recruiting
- Coronary Artery Disease Progression
- Intensive lipid-lowering control
- Moderate-intensity lipid-lowering control
- (no location specified)
Jul 13, 2022
Cardiovascular Risk Factor Trial in Paris (CCS wit CT Scann measurement)
Completed
- Cardiovascular Risk Factor
- CCS wit CT Scann measurement
-
Paris, FranceBenkessou
Mar 8, 2022
Cardiovascular Events in a High-risk Firefighter Population
Terminated
- High Cardiovascular Risk
- Firefighter
- stress test
-
Saint-Étienne, FranceCentre Hospitalier Universitaire
Dec 21, 2021
Obstructive Hypertrophic Cardiomyopathy
Completed
- Microvascular Dysfunction
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital, China National Center for Cardiovascular Disease
Jan 11, 2023
GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2
Recruiting
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- PCI
-
Naples, ItalyCelestino Sardu
Aug 31, 2023
Carotid Plaque Length to Predict Cardiovascular Events
Active, not recruiting
- Coronary Artery Disease
-
Wuxi, Jiangsu, China
- +4 more
Jun 3, 2022
Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque Trial in Bucharest (PCI revascularization strategy based on
Recruiting
- Multivessel Coronary Artery Disease
- +3 more
- PCI revascularization strategy based on combined FFR and OCT assessment
- PCI revascularization strategy based FFR assessment
-
Bucharest, RomaniaDifferent countries in Europe, Asia Pacific and Canada
Apr 11, 2022
Death and Cardiovascular Events in PD Patients
Recruiting
- Peritoneal Dialysis
- Inflammation
- monocyte / lymphocyte ratio
-
Guangzhou, Guangdong, ChinaZhujiang Hospital, Southern Medical University
Mar 31, 2022
Cardiovascular Events Among Adults Relapsed or Refractory
Recruiting
- Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
- +9 more
- Electronic Health Record Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Intracranial Hemorrhages Trial in Hamilton (Colchicine Pill, Placebo)
Recruiting
- Intracranial Hemorrhages
- Colchicine Pill
- Placebo
-
Hamilton, Ontario, CanadaHamilton Health Sciences
Aug 12, 2022
Troponin to Detect Major Cardiovasculaire Advserse Events on
Recruiting
- Cancer
- +2 more
- No intervention
-
Paris, FranceInstitut Mutualiste Montsouris
Aug 22, 2023
In-stent Restenosis, Major Adverse Cardiovascular Events Trial in Beijing (PCSK9 inhibitor, Statin)
Recruiting
- In-stent Restenosis
- Major Adverse Cardiovascular Events
- PCSK9 inhibitor
- Statin
-
Beijing, Beijing, ChinaBeijing Anzhen Hospital
Jan 16, 2023
Shock Factor: Effects of Surprise on Cardiovascular Responses.
Recruiting
- Physiologic Responses to Surprise Events
- Surprise events
-
Keswick, Ontario, CanadaPlaySafe Productions
Dec 15, 2022
Acute Cardiovascular Adverse Events Occuring in Children Treated
Not yet recruiting
- Malignancies
- +2 more
- use of anticancer drugs in monotherapy or in combination therapy
- (no location specified)
Oct 27, 2022
Major Adverse Cardiovascular Events for Naldemedine and Other
Recruiting
- Opioid-induced Constipation
- Naldemedine
- +2 more
-
Wilmington, DelawareResearch Site
Feb 28, 2022